1224103-89-2

Upstream product

• 64-17-5 ethanol 
• 1224103-88-1 C₁₈H₁₆F₂O₃ 
• 100-39-0 benzyl bromide 
• 1224103-63-2 ethyl (2E)-3-(3,5-difluoro-4-hydroxyphenyl)prop-2-enoate 
• 1224103-87-0 C₁₈H₁₆F₂O₂ 
• 1234844-98-4 C₁₉H₁₈F₂O₂ 
• 1224103-67-6 C₁₇H₁₄F₂O₂ 
• 1224103-66-5 (2-(4-(benzyloxy)-3,5-difluorophenyl)-cyclopropyl)methanol 
• 1224103-65-4 2-(4-benzyloxy-3,5-difluorophenyl)cyclopropanecarboxylic acid ethyl ester 
• 1224103-64-3 2-(3,5-difluoro-4-hydroxyphenyl)cyclopropanecarboxylic acid ethyl ester 
• 104197-13-9 4-bromo-2,6-difluorophenol 

Downstream Products

• 1224103-68-7 ethyl 2-(2-(3,5-difluoro-4-hydroxyphenyl)cyclopropyl)acetate 

Relevant academic research and scientific papers

GPR120 RECEPTOR AGONISTS AND USES THEREOF

GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.

GPR120 RECEPTOR AGONISTS AND USES THEREOF

GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.

ARYL GPR120 RECEPTOR AGONISTS AND USES THEREOF

Aryl GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.